Although several animal models have been proposed in order to understand the pathogenesis of NAFLD [47], the possible neoplastic transformation that characterizes end-stage NASH has been developed in only a few models, including aged gal3−/− mice [18, 48]. This evidence concerns the gene LGALS3 and metabolic dysfunction-associated steatotic liver disease.